MoneyWorks4Me

Par Drugs & Chem. - Quaterly Results

09 Nov 2021 Evaluate
A fair growth of 14.14% in the revenue at Rs. 195.95 millions was reported in the September 2021 quarter as compared to Rs. 171.67 millions during year-ago period.A big decline of -36.70% was reported for the quarter ended September 2021 to Rs. 22.20  millions from Rs. 35.07 millions of corresponding previous quarter.A decline of 40.72 millions was observed in the OP in the quarter ended September 2021 from 51.26 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 195.95 171.67 14.14 195.95 171.67 14.14 607.51 558.49 8.78
Other Income 0.28 0.30 -6.67 0.28 0.30 -6.67 1.89 0.99 90.91
PBIDT 40.72 51.26 -20.56 40.72 51.26 -20.56 162.02 95.47 69.71
Interest 2.28 2.78 -17.99 2.28 2.78 -17.99 6.42 7.94 -19.14
PBDT 38.44 48.48 -20.71 38.44 48.48 -20.71 175.46 87.53 100.46
Depreciation 8.35 7.36 13.45 8.35 7.36 13.45 28.19 27.62 2.06
PBT 30.09 41.12 -26.82 30.09 41.12 -26.82 147.27 59.91 145.82
TAX 7.89 6.05 30.41 7.89 6.05 30.41 31.15 12.27 153.87
Deferred Tax 0.00 -0.66 0.00 0.00 -0.66 0.00 -2.46 2.27 -208.37
PAT 22.20 35.07 -36.70 22.20 35.07 -36.70 116.12 47.64 143.74
Equity 123.05 61.52 100.02 123.05 61.52 100.02 61.52 61.52 0.00
PBIDTM(%) 20.78 29.86 -30.40 20.78 29.86 -30.40 26.67 17.09 56.01
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..